Top 10 Healthcare Market Research Providers for Business Development

 

In today’s fast-paced healthcare environment, market intelligence is a strategic necessity for pharma companies, medtech manufacturers, payers, and investors. Accurate, timely insights guide product strategy, portfolio planning, M&A evaluation, and market entry decisions. As the sector increasingly leverages real-world evidence (RWE), artificial intelligence (AI), and advanced analytics, choosing the right market research partner can significantly impact business development outcomes.

This article presents the top 10 healthcare market research providers for 2025, evaluated for data depth, analytic sophistication, therapeutic expertise, client services, and overall strategic impact. These providers are essential for executives seeking actionable insights that drive growth and competitive advantage.

1. IQVIA – Global Leader in Healthcare Data and Analytics

IQVIA is recognized as a global leader in healthcare data and analytics. Its Connected Intelligence platform integrates claims data, electronic medical records, prescription and provider information, clinical trial execution, and commercial performance metrics.

Business development teams leverage IQVIA for launch strategy, market forecasting, portfolio optimization, and real-world evidence programs. The IQVIA Institute’s research publications remain a go-to source for executives planning global product launches or evaluating therapy areas.

IQVIA’s strength lies in its ability to provide comprehensive, end-to-end analytics at scale, making it ideal for organizations requiring enterprise-wide insights.

2. Clarivate – Integrated Life Science Intelligence

Clarivate has consolidated multiple life-science intelligence assets, including Decision Resources Group (DRG), under a single platform. This integration provides access to clinical, commercial, and payer datasets, combined with expert analyst coverage for asset valuation, competitive landscaping, and product strategy.

For business development, Clarivate enables portfolio prioritization, licensing evaluation, and market opportunity assessment. Its proprietary databases, workflow tools, and expert networks ensure decisions are based on high-quality, actionable intelligence.

Clarivate is particularly suitable for organizations seeking enterprise-scale intelligence with global reach and multi-therapeutic coverage.

3. Evaluate – Pharmaceutical Forecasting and Deal Intelligence

Evaluate specializes in commercial forecasting and consensus modeling for the pharmaceutical industry. Its offerings include Evaluate Pharma, Biomedtracker, and Pharmapremia, which provide forward-looking sales projections, pipeline probability assessments, and M&A intelligence.

Business development teams use Evaluate to stress-test valuation models, plan investor communications, and support due diligence. Its consensus forecasts and sector reports are particularly valuable for companies involved in licensing negotiations or corporate strategy planning.

Evaluate is ideal for organizations seeking quantitative, data-driven insights to inform high-stakes strategic decisions.

4. DelveInsight – Therapy-Focused Research and Consulting

DelveInsight is a specialized healthcare market research and consulting firm with deep expertise across pharma and medtech therapy areas. The company provides market access analyses, pipeline landscapes, competitive intelligence, and clinical development insights tailored to mid-sized biotechs and global pharmaceutical teams.

For business development, DelveInsight delivers actionable, therapy-specific intelligence that supports licensing decisions, market entry, and portfolio optimization. Its consultative approach combines specialist analysts with customized research, ensuring insights are practical and immediately applicable.

DelveInsight is particularly effective when organizations require focused, high-value intelligence in specific therapeutic areas to complement broader enterprise datasets.

5. Informa / Pharma Intelligence – Clinical Trial and Regulatory Insights

Informa’s Pharma Intelligence, along with its specialist intelligence brands, provides clinical trial intelligence, regulatory tracking, and commercial analytics. Its platforms offer detailed insights into pipeline activity, investigator networks, trial performance, and regulatory developments.

Business development teams rely on Informa for clinical program benchmarking, competitive analysis, and regulatory guidance, helping to inform licensing, partnerships, and go-to-market strategies.

Informa’s scale and industry access make it a strong choice for global program monitoring and tactical launch planning.

6. Frost & Sullivan – Growth Strategy and Market Opportunity Analytics

Frost & Sullivan integrates market research with growth consulting and scenario planning, helping organizations identify emerging opportunities in medtech, digital health, and healthcare IT. Its reports and forecasts enable companies to spot white-space markets, prioritize investments, and optimize growth strategies.

For business development, Frost & Sullivan translates data into actionable market-entry and go-to-market strategies, helping organizations maximize ROI on new products or services.

Its strength lies in combining research insights with practical advisory services, particularly for companies entering new therapeutic or geographic markets.

7. McKinsey & Company – Life Sciences and Healthcare Insights

McKinsey’s Life Sciences and Healthcare practice offers a unique combination of market intelligence and operational expertise. While not a pure data vendor, McKinsey provides proprietary benchmarking, advanced analytics, and strategic advisory services.

Business development teams utilize McKinsey to align market insights with operational initiatives, including global launch sequencing, portfolio optimization, pricing strategy, and digital transformation projects.

McKinsey is particularly valuable when intelligence must be directly linked to enterprise execution and transformation initiatives.

8. GlobalData Healthcare – Data-Driven Competitive Intelligence

GlobalData Healthcare provides data-rich insights, pipeline tracking, company profiles, and market forecasts. Its platforms help teams monitor competitors, evaluate partnership opportunities, and identify emerging trends in pharma, biotech, and medtech.

Business development teams benefit from GlobalData’s ability to deliver comprehensive sector intelligence with actionable context, supporting strategic planning, M&A decisions, and portfolio prioritization.

GlobalData is ideal for companies seeking syndicated intelligence combined with industry-specific analysis.

9. EvaluateMedTech – MedTech Market Specialization

EvaluateMedTech focuses on market intelligence for the medtech and diagnostics sector, offering pipeline monitoring, commercial analysis, and competitive benchmarking.

Business development teams use EvaluateMedTech for portfolio prioritization, product launch planning, and M&A evaluation. Its insights are highly relevant for device manufacturers and health-tech startups seeking precise, actionable market intelligence.

EvaluateMedTech excels in delivering medtech-specific intelligence that complements broader healthcare datasets.

10. GlobalData Pharma & Life Sciences Consulting – Customized Advisory

GlobalData’s consulting arm supplements its research platforms with bespoke advisory services, including commercial due diligence, licensing strategy, and market entry planning.

Business development teams leverage these services to translate data into actionable business decisions, ensuring intelligence is not only informative but operationally applicable.

GlobalData’s consulting practice is particularly beneficial for companies requiring tailored guidance alongside robust market intelligence.

Choosing the Right Market Research Provider

Selecting the ideal healthcare market research provider depends on your specific business development needs, therapeutic focus, and decision-making objectives. Key considerations include:

• Use Cases: M&A, licensing, launch strategy, or portfolio optimization.
  
  

• Data Quality and Depth: Transparency in sources, sample sizes, and methodology.
  
  

• Analytic Capabilities: AI, predictive modeling, and RWE integration.
  
  

• Integration and Delivery: Workflow compatibility, APIs, and reporting flexibility.
  
  

• Specialist vs. Generalist: Combining enterprise-scale providers with niche specialists often yields the best outcomes.
  
  

In 2025, leading providers are leveraging advanced analytics, patient-level data, and explainable AI models to accelerate insights, making careful vendor selection a competitive advantage.

Conclusion

For healthcare executives, pharma companies, medtech manufacturers, and investors, robust market intelligence is critical for business development success. IQVIA and Clarivate lead in enterprise-scale, end-to-end intelligence, Evaluate excels in forecasting and deal modeling, and DelveInsight offers deep, therapy-specific insights. Supplementing these with Informa, Frost & Sullivan, and McKinsey ensures organizations can translate data into actionable strategies, optimize portfolios, and accelerate growth in a complex and competitive healthcare landscape.